Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Discovery Laboratories Inc (NASDAQ:DSCO)

0.43
Delayed Data
As of Sep 04
 -0.031 / -6.72%
Today’s Change
0.35
Today|||52-Week Range
2.01
-62.93%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$51.2M

Company Description

Discovery Laboratories, Inc. is engaged in the manufacture and development of products for infants and respiratory diseases. It focuses on producing surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Its products include SURFAXIN and AFECTAIR. The company was founded on November 6, 1992 and is headquartered in Warrington, PA.

Contact Information

Discovery Laboratories, Inc.
2600 Kelly Road
Warrington Pennsylvania 18976-3622
P:(215) 488-9300
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

John G. CooperPresident, Chief Executive Officer & Director
John Andrew TattoryChief Financial Officer & Senior Vice President
Robert SegalSenior Vice President-Medical & Scientific Affairs
Mary B. TempletonSecretary, Senior Vice President & General Counsel
Steven G. SimonsonChief Development Officer & Senior Vice President